Publications database

Displaying 91 - 93 of 93

Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs

An enlarged EMCDDA Scientific Committee met from 18–19 May 1999 in Lisbon to assess the risks of the synthetic drug 4-MTA (4-methylthioamphetamine) in the framework of the Joint action on new synthetic...

Guidelines for the risk assessment of new synthetic drugs

This publication was drawn up by the steering group created by the EMCDDA's Scientific Committee in November 1998 to establish guidelines to assess the risks of all new synthetic drugs identified under...

Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs

On 27 February 1998, the drug MBDB (N-methyl-1-(1,3-benzodioxol- 5-yl)-2-butanamine) became the first new synthetic drug to be submitted for risk assessment under the terms of the Joint Action concerning the information exchange...